Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP2K5 divergent transcript (MAP2K5-DT) is an annotated long non-coding RNA (lncRNA) gene located near the MAP2K5 locus on human chromosome 15. It is defined by its divergent transcriptional orientation relative to the protein-coding gene MAP2K5. There is currently no evidence to suggest that MAP2K5-DT encodes a protein or acts as a therapeutic target, nor have functional roles or disease associations been clearly established in the biomedical literature[5][7].\n\nMAP2K5-DT ("MAP2K5 divergent transcript") is a long non-coding RNA with no established biological function, disease association, or role as a drug target. If your intent was to reference the kinase (MAP2K5), use "Mitogen-activated protein kinase kinase 5" (MAP2K5, MEK5). MAP2K5-DT is not currently of interest from a therapeutic targeting perspective[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAP2K5 divergent transcript (MAP2K5-DT).